{{Drugbox
| Watchedfields = changed
| verifiedrevid = 437170931
| IUPAC_name = 3-Diethylamino-1-[2-(trifluoromethyl)phenothiazin-10-yl]-propan-1-one
| image = Fluacizine.svg
| alt = Skeletal formula of fluacizine
| width = 250px
| image2 = Fluacizine 3D spacefill.png
| alt2 = Space-filling model of the fluacizine molecule
| width2 = 200px

<!--Clinical data-->
| tradename = Phtorazisin
| pregnancy_category = 
| legal_status = Rx-only
| routes_of_administration = [[Oral administration|Oral]], [[intramuscular injection]]

<!--Pharmacokinetic data-->
| bioavailability = 
| metabolism = 
| elimination_half-life = 
| excretion = 

<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 30223-48-4
| CAS_supplemental = <br />27312-93-2 ([[hydrochloride]])
| ATC_prefix = None
| ATC_suffix = 
| PubChem = 161562
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 141910
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = E2M3325B1R
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 92281
| synonyms = Fluoracizine; Fluoracyzine; Fluoracisine; Ftoracizin; Ftoracizine; Phthoracizin<ref name="Elks2014" /><ref name="MerckIndex2001" />

<!--Chemical data-->
| C=20 | H=21 | F=3 | N=2 | O=1 | S=1 
| molecular_weight = 394.455 g/mol
| SMILES = FC(F)(F)c2cc1N(c3c(Sc1cc2)cccc3)C(=O)CCN(CC)CC
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C20H21F3N2OS/c1-3-24(4-2)12-11-19(26)25-15-7-5-6-8-17(15)27-18-10-9-14(13-16(18)25)20(21,22)23/h5-10,13H,3-4,11-12H2,1-2H3
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = VHEOUJNDDFHPGJ-UHFFFAOYSA-N
}}

'''Fluacizine''', sold under the brand name '''Phtorazisin''', is a [[tricyclic antidepressant]] (TCA) of the [[phenothiazine]] group which is or was marketed in [[Russia]].<ref name="Elks2014">{{cite book|author=J. Elks|title=The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies|url=https://books.google.com/books?id=0vXTBwAAQBAJ&pg=PA555|date=14 November 2014|publisher=Springer|isbn=978-1-4757-2085-3|pages=555–}}</ref><ref name="MerckIndex2001">{{cite book | author = O'Neil, Maryadele J. | title = The Merck index: an encyclopedia of chemicals, drugs, and biologicals | publisher = Merck Research Laboratories | location = Rahway, NJ | year = 2001 | pages = | isbn = 0-911910-13-1 | oclc = | doi = | url = }}</ref><ref name="Zakusov2013">{{cite book|author=V. V. Zakusov|title=Pharmacology of Central Synapses|url=https://books.google.com/books?id=lrsgBQAAQBAJ&pg=PA190|date=22 October 2013|publisher=Elsevier|isbn=978-1-4831-4673-7|pages=190–}}</ref> Unlike other phenothiazines, fluacizine is not an [[antipsychotic]], and can actually reverse [[catalepsy]] and [[extrapyramidal symptom]]s induced by [[antidopaminergic]] agents like antipsychotics, [[reserpine]], and [[tetrabenazine]] as well as potentiate [[amphetamine]]-induced [[stereotypy]].<ref name="Zakusov2013" /> It is known to act as a [[norepinephrine reuptake inhibitor]], [[antihistamine]], and [[anticholinergic]].<ref name="pmid4153328">{{cite journal | vauthors = Arefolov VA, Panasyuk LV, Raevskii KS, Kostyukov VI | title = Effect of fluacizine on the uptake of exogenous noradrenalin by the isolated rat vas deferens | journal = Bull. Exp. Biol. Med. | volume = 77 | issue = 3 | pages = 295–7 | year = 1974 | pmid = 4153328 | doi = | url = }}</ref><ref name="pmid4441683">{{cite journal | vauthors = Arefolov VA, Panasyuk LV | title = Effect of fluacizine on the uptake of exogenous noradrenalin | journal = Bull. Exp. Biol. Med. | volume = 77 | issue = 5 | pages = 520–3 | year = 1974 | pmid = 4441683 | doi = | url = }}</ref><ref name="pmid6305">{{cite journal | vauthors = Arefolov VA, Panasiuk LV, Firsov VK | title = [Neuromediator content in the synaptic vesicles of rat adrenergic nerves in some pharmacological actions] | language = Russian | journal = Farmakol Toksikol | volume = 38 | issue = 3 | pages = 285–9 | year = 1975 | pmid = 6305 | doi = | url = }}</ref><ref name="AcademicPress1972">{{cite book|title=Annual Reports in Medicinal Chemistry|url=https://books.google.com/books?id=52joNWUvZakC&pg=PA19|date=27 October 1972|publisher=Academic Press|isbn=978-0-08-058351-8|pages=19–}}</ref><ref name="Zakusov2013" /> The drug was developed in the 1960s and was marketed in the 1970s.<ref name="Elks2014" /><ref name="pmid4153328" /> It is the [[trifluoromethyl]] [[structural analog|analogue]] of [[chloracizine]].<ref name="AcademicPress1972" />

==See also==
* [[Pipofezine]]

==References==
{{Reflist|2}}

{{Antidepressants}}
{{Navboxes
| title = [[Pharmacodynamics]]
| titlestyle = background:#ccccff
| list1 = 
{{Histamine receptor modulators}}
{{Monoamine reuptake inhibitors}}
{{Muscarinic acetylcholine receptor modulators}}
}}
{{Tricyclics}}

[[Category:Abandoned drugs]]
[[Category:Amines]]
[[Category:Antidepressants]]
[[Category:Carboxamides]]
[[Category:Drugs in the Soviet Union]]
[[Category:H1 receptor antagonists]]
[[Category:Muscarinic antagonists]]
[[Category:Norepinephrine reuptake inhibitors]]
[[Category:Phenothiazines]]
[[Category:Russian drugs]]
[[Category:Trifluoromethyl compounds]]


{{Nervous-system-drug-stub}}